These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12214466)

  • 21. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
    Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ
    J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancer.
    Gemma A; Seike M; Kosaihira S; Minegishi Y; Noro R; Nara M; Hosomi Y; Okano T; Kokubo Y; Yoshimura A; Shibuya M; Kudoh S
    Anticancer Res; 2006; 26(4B):3083-7. PubMed ID: 16886638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
    Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
    Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer.
    Fukuda M; Soda H; Soejima Y; Fukuda M; Kinoshita A; Takatani H; Kasai T; Nagashima S; Kawabata S; Doi S; Kohno S; Oka M
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):601-6. PubMed ID: 16463061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
    Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G
    Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: long-term results of a phase II study.
    Jeremić B; Milicić B; Acimović L; Milisavljević S
    J Clin Oncol; 2005 Oct; 23(28):6873-80. PubMed ID: 16192579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.
    Inoue A; Usui K; Ishimoto O; Matsubara N; Tanaka M; Kanbe M; Gomi K; Koinumaru S; Saijo Y; Nukiwa T
    Lung Cancer; 2006 Apr; 52(1):83-7. PubMed ID: 16483687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effective combination chemotherapy using paclitaxel in the treatment of a small-cell lung cancer patient resistant to multiple drugs].
    Yoshida T; Mori K; Kamiyama Y; Tominaga K
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1437-40. PubMed ID: 11681253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase I clinical study of combined cisplatin and carboplatin therapy in lung cancer].
    Hayasaka S; Yoshinaga T; Kinuwaki E; Kiyama T; Fujino N
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2011-6. PubMed ID: 1417008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic re-evaluation and phase I study of high dose epirubicin in advanced non-small cell lung cancer.
    Nishio M; Ohata M; Kobayashi H; Suruda T; Uetani K; Funasako M; Nishio K; Sasaki Y; Saijo N
    Jpn J Clin Oncol; 1993 Oct; 23(5):284-90. PubMed ID: 8230753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer.
    Morère JF; Piperno-Neumann S; Coulon MA; Vaylet F; L'Her P; Brunet A; Quinaux E; Breau JL
    Anticancer Drugs; 2000 Aug; 11(7):541-8. PubMed ID: 11036956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A phase I study on a weekly schedule of DWA2114R].
    Niitani H; Fukuoka M; Furusawa M; Tamura M; Hasegawa K; Kurita Y; Ariyoshi Y; Matsunaga T; Kumoi T; Kimura I
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1027-32. PubMed ID: 1626938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial of carboplatin and weekly paclitaxel in patients with advanced non-small-cell lung cancer.
    Kikuchi J; Yamazaki K; Kinoshita I; Asahina H; Imura M; Kikuchi E; Konishi J; Shinagawa N; Oki H; Dosaka-Akita H; Nishimura M
    Jpn J Clin Oncol; 2004 Sep; 34(9):505-9. PubMed ID: 15466822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phase I study of docetaxel combined with carboplatin in patients with non-small cell lung cancer].
    Zhu LM; Li QY; Yu XM; Ma SL
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):946-8. PubMed ID: 17533750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy with high dose CBDCA for advanced non-small cell lung cancer].
    Daido K; Arita K; Ejima T
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):123-5. PubMed ID: 1309631
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combination chemotherapy of carboplatin and docetaxel for advanced non-small cell lung cancer (NSCLC)].
    Bando H; Miyata J; Sano T; Sumitomo M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):947-52. PubMed ID: 11478143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer.
    Shimada M; Kigawa J; Terakawa N; Yoshizaki A; Shoji T; Suzuki M; Hatae M; Tsuda H; Ohwada M; Sugiyama T
    Int J Gynecol Cancer; 2007; 17(1):210-4. PubMed ID: 17291255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility trial of adjuvant chemotherapy with paclitaxel and carboplatin after surgical resection in Japanese patients with non-small cell lung cancer: report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0501.
    Maruyama R; Yoshino I; Tokunaga S; Ohta M; Kato M; Yoshimine H; Yamazaki K; Nakanishi Y; Ichinose Y
    Gen Thorac Cardiovasc Surg; 2008 Feb; 56(2):68-73. PubMed ID: 18297461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I-II study of biweekly paclitaxel administration with fixed-dose-rate cisplatin in advanced gastric cancer.
    Yamaguchi K; Shimamura T; Komatsu Y; Takagane A; Yoshioka T; Saitoh S; Munakata M; Sakata Y; Sato T; Arai T; Saitoh H;
    Gastric Cancer; 2006; 9(1):36-43. PubMed ID: 16557435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.